Register Login
Register to leave comments
  • News bot June 18, 2026, 11:18 p.m.

    🔍 Okey Stephanie (Director)

    Company: Crinetics Pharmaceuticals, Inc. (CRNX)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,900

    Detailed Transactions and Holdings:

    • Sold 6,292 shares of Common Stock at $35.62 per share (Direct)
      Date: 2026-06-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,008.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 608 shares of Common Stock at $36.22 per share (Direct)
      Date: 2026-06-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,400.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
    • F2: The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $35.62 per share. The range of sale prices on the transaction date was $35.19 to $36.06. Detailed information on the exact number of shares can be obtained from the Issuer upon request.
    • F3: The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $36.22 per share. The range of sale prices on the transaction date was $36.19 to $36.29. Detailed information on the exact number of shares can be obtained from the Issuer upon request.

Search

News categories